Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ FCER1G Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA528832
Description
Recommended positive controls: Fc epsilonRIgamma tansfected 293T cell. Predicted reactivity: Rat (100%), Dog (100%), Pig (100%), Rhesus Monkey (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The high affinity IgE receptor is a key molecule involved in allergic reactions. It is a tetramer composed of 1 alpha, 1 beta, and 2 gamma chains. The gamma chains are also subunits of other Fc receptors.
Specifications
FCER1G | |
Polyclonal | |
Unconjugated | |
FCER1G | |
AI573376; CD23; Fc epsilon receptor Ig; Fc fragment of IgE receptor Ig; Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide; Fc receptor gamma-chain; Fc receptor, IgE, high affinity I, gamma polypeptide; Fce1g; fc-epsilon RI-gamma; FcepsilonRI; FCER1G; FceRI gamma; FcR[g]; FCRG; FcRgamma; FcR-gamma; gamma polypeptide; high affinity immunoglobulin epsilon receptor subunit gamma; IgE Fc receptor subunit gamma; immunoglobulin E receptor, high affinity, gamma chain; Ly-50 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
14127, 2207 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot, Immunocytochemistry | |
0.73 mg/mL | |
PBS with 20% glycerol and 0.025% ProClin 300; pH 7 | |
P20491, P30273 | |
FCER1G | |
Synthetic peptide encompassing a sequence within the Intracellular domain of human FCER1G. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction